Valneva announces pricing of €102.9 million global offering of american depositary shares and ordinary shares

Saint herblain (france), september 30, 2022 – valneva se (nasdaq: valn; euronext paris: vla) (the “company”), a specialty vaccine company, announced today the pricing of 21,000,000 ordinary shares in a global offering to specified categories of investors comprised of a public offering of 375,000 american depositary shares (“adss”), each representing two ordinary shares, in the united states (the “u.s. offering”) and a concurrent private placement of 20,250,000 ordinary shares in certain jurisdictions outside of the united states (the “european private placement” and together with the u.s. offering, the “global offering”).
VALN Ratings Summary
VALN Quant Ranking